Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-102 for abdominal fat reduction
NCT01180465Phase 2Completed
- Sponsor
- Neothetics
- Start
- Apr 2010
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, fluticasone propionate in Abdominal adiposity (ABCD), sponsored by Neothetics. Started Apr 2010; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
Abdominal adiposity (ABCD)
Beyond the preview
Go deeper on NCT01180465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180465.